EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A pathway-level analysis reveals oxidative and inflammatory vascular stress signatures associated with VEGF inhibition

Jean Carlos Lipreri da Silva, Grace Whelan, Filipe de Farias F Martins, Tiago J Costa, Karla Bianca Neves

Vascular Pharmacology · 2026-12 · 165 · 107718

DOI: 10.1016/j.vph.2026.107718 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vascular Pharmacology, 2026-12. Verfasst von Jean Carlos Lipreri da Silva und 4 weiteren Autor:innen. Beteiligte Einrichtung: Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK; Department of Pharmacology - Institute of Biomedic…. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Royal Society, Royal Society of Edinburgh, National Council for Scientific and Technological Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vascular endothelial growth factor inhibitors (VEGFi) are widely used in the treatment of advanced malignancies, including clear cell renal cell carcinoma (ccRCC), but are frequently associated with cardiovascular toxicities such as hypertension and endothelial dysfunction. The molecular mechanisms underlying these adverse effects remain incompletely understood. In this study, we performed an integrated transcriptomic and functional analysis to characterise vascular stress responses associated with VEGFi. Pre-treatment tumour RNA sequencing data from a public cancer cohort were analysed using Gene Set Enrichment Analysis (GSEA) to identify pathway-level signatures associated with subsequent VEGFi treatment. No individual genes remained significant after multiple testing correction; therefore, emphasis was placed on coordinated biological responses. Functional validation was conducted in human vascular cells treated with a VEGFi to assess reactive oxygen species (ROS) production, cytokine levels and expression, and extracellular vesicles (EVs) release. Pathway analysis revealed significant baseline enrichment of oxidative stress, inflammatory response, and nuclear factor-kappa B (NF-κB) signalling pathways in tumours of patients who subsequently received VEGFi. These baseline associations were complemented by increased vascular cell ROS production and enhanced EVs release in vitro. Inflammatory activation was further confirmed by increased cytokine secretion, despite unchanged messenger RNA expression, indicating regulation at post-transcriptional and secretory levels. Collectively, these baseline tumour signatures and the in vitro vascular findings are consistent with a model in which VEGF inhibition induces a coordinated redox-inflammatory response, which may involve EV-mediated intercellular communication. This mechanism may contribute to vascular dysfunction and cardiovascular toxicity associated with VEGFi-targeted therapies.

Schlagwörter

Stichwörter der Autor:innen

CancerExtracellular vesiclesNF-κBOxidative stressVEGF inhibitionVascular toxicity

Autor:innen und Institutionen

  • Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK; Department of Pharmacology - Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
  • Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.
  • Department of Pharmacology - Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
  • Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK. Electronic address: karla.neves@strath.ac.uk.

Förderung

  • The Royal Society
  • Royal Society of Edinburgh
  • National Council for Scientific and Technological Development
  • University of Sao Paulo
  • University of Strathclyde
  • Tenovus
  • D'Or Institute for Research and Education
  • Coordination for the improvement of Higher Education Personnel

Zitieren

APA

Lipreri da Silva, J. C., Whelan, G., Martins, F. F. F., Costa, T. J., & Neves, K. B. (2026). A pathway-level analysis reveals oxidative and inflammatory vascular stress signatures associated with VEGF inhibition. Vascular Pharmacology, 165, 107718. https://doi.org/10.1016/j.vph.2026.107718

Vancouver

Lipreri da Silva JC, Whelan G, Martins FFF, Costa TJ, Neves KB. A pathway-level analysis reveals oxidative and inflammatory vascular stress signatures associated with VEGF inhibition. Vascular Pharmacology. 2026;165:107718. doi:10.1016/j.vph.2026.107718

BibTeX
@article{LipreridaSilva2026,
  author = {Lipreri da Silva, Jean Carlos and Whelan, Grace and Martins, Filipe de Farias F and Costa, Tiago J and Neves, Karla Bianca},
  title = {A pathway-level analysis reveals oxidative and inflammatory vascular stress signatures associated with VEGF inhibition},
  journal = {Vascular Pharmacology},
  year = {2026},
  volume = {165},
  pages = {107718},
  doi = {10.1016/j.vph.2026.107718}
}
Kostenlos starten →